Skip to main content
Erschienen in: Current Treatment Options in Gastroenterology 4/2017

25.08.2017 | Pancreas (V Chandrasekhara, Section Editor)

Diagnosis and Management of Autoimmune Pancreatitis

verfasst von: Phil A. Hart, MD, Somashekar G. Krishna, MD, MPH, Kazuichi Okazaki, MD

Erschienen in: Current Treatment Options in Gastroenterology | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Opinion statement

Although autoimmune pancreatitis is a relatively uncommon pancreatic disorder, it is an important consideration in the differential diagnosis of jaundice and pancreatic masses to avoid unnecessary surgical resection. The clinical diagnosis of autoimmune pancreatitis involves considering multiple pieces of information including the pancreatic imaging, serum IgG4 level, presence of characteristic other involvement, and histologic findings. Unlike other pancreatic disorders, this condition rapidly responds to treatment with steroids. In the more common disease subtype (type 1 autoimmune pancreatitis) disease relapses can occur necessitating the use of maintenance treatment with low-dose steroids, steroid-sparing immunomodulators, or rituximab. This chapter reviews the diagnosis and treatment of the autoimmune pancreatitis subtypes.
Literatur
1.
Zurück zum Zitat Longnecker D. Evolution of the concept of autoimmune pancreatitis and its subtypes Pancreapedia: Exocrine Pancreas Knowledge Base. 2013. Longnecker D. Evolution of the concept of autoimmune pancreatitis and its subtypes Pancreapedia: Exocrine Pancreas Knowledge Base. 2013.
2.
Zurück zum Zitat Kawaguchi K, Koike M, Tsuruta K, Okamoto A, Tabata I, Fujita N. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol. 1991;22(4):387–95.CrossRefPubMed Kawaguchi K, Koike M, Tsuruta K, Okamoto A, Tabata I, Fujita N. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol. 1991;22(4):387–95.CrossRefPubMed
3.
Zurück zum Zitat Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40(7):1561–8.CrossRefPubMed Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40(7):1561–8.CrossRefPubMed
4.
Zurück zum Zitat Chari ST, Singer MV. The problem of classification and staging of chronic pancreatitis. Proposals based on current knowledge of its natural history. Scand J Gastroenterol. 1994;29(10):949–60.CrossRefPubMed Chari ST, Singer MV. The problem of classification and staging of chronic pancreatitis. Proposals based on current knowledge of its natural history. Scand J Gastroenterol. 1994;29(10):949–60.CrossRefPubMed
5.
Zurück zum Zitat Notohara K, Burgart LJ, Yadav D, Chari S, Smyrk TC. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol. 2003;27(8):1119–27.CrossRefPubMed Notohara K, Burgart LJ, Yadav D, Chari S, Smyrk TC. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol. 2003;27(8):1119–27.CrossRefPubMed
19.
Zurück zum Zitat Hart PA, Chari S. Diagnosis of Autoimmune Pancreatitis. Pancreapedia: Exocrine Pancreas Knowledge Base. 2013. Hart PA, Chari S. Diagnosis of Autoimmune Pancreatitis. Pancreapedia: Exocrine Pancreas Knowledge Base. 2013.
21.
Zurück zum Zitat •• Okazaki K, Chari ST, Frulloni L, Lerch MM, Kamisawa T, Kawa S, et al. International consensus for the treatment of autoimmune pancreatitis. Pancreatology. 2017;17(1):1–6. https://doi.org/10.1016/j.pan.2016.12.003. Consensus recommendations from the International Association of Pancreatology regarding the management of autoimmune pancreatitis. CrossRefPubMed •• Okazaki K, Chari ST, Frulloni L, Lerch MM, Kamisawa T, Kawa S, et al. International consensus for the treatment of autoimmune pancreatitis. Pancreatology. 2017;17(1):1–6. https://​doi.​org/​10.​1016/​j.​pan.​2016.​12.​003. Consensus recommendations from the International Association of Pancreatology regarding the management of autoimmune pancreatitis. CrossRefPubMed
25.
Zurück zum Zitat • Masamune A, Nishimori I, Kikuta K, Tsuji I, Mizuno N, Iiyama T, et al. Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis. Gut. 2017;66(3):487–94. https://doi.org/10.1136/gutjnl-2016-312049. Randomized clinical trial comparing the use of maintenance steroids versus no maintenance treatment for maintenance of disease remission. CrossRefPubMed • Masamune A, Nishimori I, Kikuta K, Tsuji I, Mizuno N, Iiyama T, et al. Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis. Gut. 2017;66(3):487–94. https://​doi.​org/​10.​1136/​gutjnl-2016-312049. Randomized clinical trial comparing the use of maintenance steroids versus no maintenance treatment for maintenance of disease remission. CrossRefPubMed
Metadaten
Titel
Diagnosis and Management of Autoimmune Pancreatitis
verfasst von
Phil A. Hart, MD
Somashekar G. Krishna, MD, MPH
Kazuichi Okazaki, MD
Publikationsdatum
25.08.2017
Verlag
Springer US
Erschienen in
Current Treatment Options in Gastroenterology / Ausgabe 4/2017
Print ISSN: 1092-8472
Elektronische ISSN: 1534-309X
DOI
https://doi.org/10.1007/s11938-017-0147-x

Weitere Artikel der Ausgabe 4/2017

Current Treatment Options in Gastroenterology 4/2017 Zur Ausgabe

Motility (H Parkman and R Schey, Section Editors)

Diabetes and the Small Intestine

Motility (H Parkman and R Schey, Section Editors)

Diabetes Mellitus and the Colon

Pancreas (V Chandrasekhara, Section Editor)

Pancreatic Cancer Screening

Motility (H Parkman and R Schey, Section Editors)

Diabetes and the Esophagus

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.